Morgan Stanley Amarin Corp Plcuk Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Morgan Stanley holds 3,610,315 shares of AMRN stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,610,315
Previous 5,563,083
35.1%
Holding current value
$2.49 Million
Previous $4.84 Million
33.6%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMRN
# of Institutions
184Shares Held
87.9MCall Options Held
528KPut Options Held
219K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$17.1 Million3.87% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12MShares$8.3 Million1.12% of portfolio
-
Dg Capital Management, LLC New York, NY6.44MShares$4.45 Million3.54% of portfolio
-
Eversept Partners, LP New York, NY6.21MShares$4.29 Million0.42% of portfolio
-
Two Sigma Investments, LP New York, NY3.39MShares$2.34 Million0.01% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $278M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...